User Name Password Remember Me  
 
 
   
Video Podcast
Audio Cast
Mobile(WAP)
  Pedi Poll  
With CET being compulsory for post graduate medical education do medical students neglect MBBS clinical studies?
Yes
No
  Translate This Page  
 
UPDATE ON PATENT DUCTUS ARTERIOSUS
NCPCC 2005

Pratibha Agarwal
Consultant, Neonatal Intensive Care Unit, KK Women’s and Children’s Hospital,
Singapore.

Ductus arteriosus provides a detour for fetal blood to bypass fluid filled lungs and it closes functionally within hours after birth and structurally within the first few days of life.

Patent Ductus Arteriosus (PDA) remains a common problem for the pre term infant in whom it is more likely to remain patent or re-open after initial closure.

The incidence of PDA is inversely related with gestational age and varies from 20% in pre term infants> 32 weeks to 60% - <28 weeks gestation. Pre term infants with PDA are at increased risk of pulmonary congestion, hemorrhagic pulmonary edema, and chronic lung disease. Redistribution of systemic blood flow with shunts across PDA results in “diastolic steal” and decreased flow to major organs with higher risk of NEC, renal impairment, IVH.

Clinical features of symptomatic PDA include cardiac murmur, bounding pulses, widened pulse pressure, hyperactive pre-corduim, deterioration in respiratory status. However, clinical signs are poor at detecting PDA in the first 4 days of life with low sensitivity ranging from 37% to 72%.

Echocardiography is the method of choice for diagnosis of PDA and includes, demonstration of left to right shunt, ductal diameter> 1.5 mm, LA:Ao ratio> 1.5 and retrograde diastolic flow in the descending aorta exceeding 30% of antegrade flow. Recent advances include elevated cardiac natriuretic peptides in the presence of delayed closure of the ductus and may potentially be used as a rapid diagnostic tool.

Management strategies of the PDA include 3 broad groups: prophylactic “closure”, closure of the asymptomatic but clinically detected PDA and closure of the symptomatic PDA. Interventions include fluid restriction, use of diuretics, use of cyclo-oxygenase inhibitors and surgical closure.

Issues that will be discussed are: role of prophylactic versus symptomatic treatment of PDA, prolonged versus short course of indomethacin, ibuprofen vs. indomethacin, surgical treatment vs. indomethacin.

The neonatal clinician and echocardiographer must remain wary of occult congenital heart disease, particularly before closing the ductus. Infants with persistent patency of the ductus arteriosus beyond the early neonatal period should be followed closely during infancy.

Last Updated on 15-05-2006

How to cite this url
NCPCC 2005 - Conference Abstracts.Pediatric Oncall [serial online] 2006 [cited 15 May 2006(Supplement 5)];3. Available from:
http://www.pediatriconcall.com/fordoctor/Conference_abstracts/PDA.asp
 
  Grants  
 » Apply For Research Grant
  Search  
Hospitals
Pediatrician
Special Schools
Medical Colleges
Pediatric Residency
Pediatric Conferences
Jobs & Vacancies
Journals
NGO's
  Ped Tools  
Pediatric Calculator
Drug Index
Medical Equipment
Vaccine Reminder
Adverse Drug Reactions
Biochemical Profile
Online MCQ's
  Calculators  
+ Growth
+ Conversion
+ Renal
+ Pregnancy
+ Blood Pressure
+ Blood Group
+ Critical Care
+ Drug Dose
+ Diarrhea Solution
+ Reference Values
+ Antibody Test
+ Drug Interaction
 
 
Parent Corner l Kids Corner l Terms & Condition | Privacy Statement l Advertising l Feedback l Awards
About Us
l Link to Us l Site Map l Shopping Mall  
Partner Sites
 HIV in Children  Infection in Children  Pedcall  Medical ADRIS  Vaccine Reminder  Pediatric Oncall Journal

Copyright© 2000-2008 All rights reserved with Pediatric Oncall

Disclaimer:The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitue an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.

 
Sitemap For Doctor | Sitemap For Parent | Sitemap For Kids Site designed and maintained by Levioza